Werbung
Revance Therapeutics Aktie Analyse
| 11.06.19 | Revance Therapeutics overweight | Barclays Capital | |
| 14.02.19 | Revance Therapeutics Buy | H.C. Wainwright & Co. | |
| 20.04.18 | Revance Therapeutics Buy | Mizuho | |
| 27.03.18 | Revance Therapeutics Buy | Needham & Company, LLC | |
| 06.12.17 | Revance Therapeutics Buy | Mizuho | |
| 27.11.17 | Revance Therapeutics overweight | Barclays Capital | |
| 17.11.17 | Revance Therapeutics Buy | Mizuho | |
| 14.06.16 | Revance Therapeutics buy | SunTrust | |
|
Werbung
|
|||
| 23.03.16 | Revance Therapeutics Buy | SunTrust Robinson Humphrey, Inc. | |
| 09.12.14 | Revance Therapeutics Outperform | William Blair | |
Werbung
Werbung